Due to the unprecedented demand on our Infoline and Ask The Nurse services, we have added additional staff to support you.
Please continue to contact us and visit our dedicated COVID-19 Information Hub for the latest information on how measures may apply to you.

Solitary plasmacytoma

This type of cancer can sometimes progress to myeloma.

What is solitary plasmacytoma?

A solitary plasmacytoma is a discreet, single mass of abnormal (cancerous) plasma cells which can occur in bone or in soft tissue.

Some patients diagnosed with a solitary plasmacytoma will go on to develop myeloma. In general, the risk of progression to myeloma is higher in patients with a solitary bone plasmacytoma (SBP) compared to those with a solitary extramedullary plasmacytoma (SEP). Patients with either type of solitary plasmacytoma are monitored regularly for signs and symptoms that may indicate progression to myeloma.

How is solitary plasmacytoma diagnosed?

A person is diagnosed with a solitary plasmacytoma through tests and investigations such as a bone marrow biopsy, an imaging scan such as an X-ray, and blood tests.

How are solitary plasmacytomas treated?

Solitary plasmacytomas are most commonly treated using radiotherapy.

Further reading

Other important information

Myeloma Matters

Myeloma Matters

Free tri-annual myeloma specific magazine. Sign up for more details.

AL amyloidosis Matters

AL amyloidosis Matters

Free twice yearly AL amyloidosis specific newsletter, sign up for more details.

Help & Support: Speak to one of our trained and qualifed Myeloma Information Specialists or email us